Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE IS EXPECTED TO REACH USD 2.29 BILLION BY 2029 FROM USD 972.07 MILLION IN 2023, GROWING AT A CAGR OF 15.36% DURING THE FORECAST PERIOD.
The Fractional Flow Reserve Market Size, Share, & Trends Analysis Report By
- Technology: Non-invasive Monitoring and Invasive Monitoring (FFR Guidewires and FFR Systems)
- Applications: Single-Vessel and Multi-Vessel
- End-User: Hospitals, Office-based Labs, Diagnostic Imaging Centers, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL FRACTIONAL FLOW RESERVE MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2029) | USD 2.29 Billion |
| Market Size (2023) | USD 972.07 Million |
| CAGR (2023-2029) | 15.36% |
| HISTORIC YEAR | 2020-2022 |
| BASE YEAR | 2023 |
| FORECAST YEAR | 2024-2029 |
| SEGMENTS BY | Technology, Applications, End-user, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | Abbott, ACIST Medical Systems, Boston Scientific, CathWorks, GE Healthcare, HeartFlow, Keya Medical, Koninklijke Philips, Opsens Medical (Haemonetics), and Siemens Healthineers |
MARKET OVERVIEW
The global fractional flow reserve market size was valued at USD 972.07 million in 2023 and is expected to reach USD 2.29 billion by 2029, growing at a CAGR of 15.36% during the forecast period. The market has grown substantially over the past decade and is projected to continue its upward trajectory. The market is poised for significant growth, driven by the rising prevalence of cardiovascular diseases, technological advancements, and increasing adoption of minimally invasive procedures. With continuous innovations and expanding applications, FFR is set to become an indispensable tool in diagnosing and managing coronary artery diseases. As healthcare systems worldwide continue to evolve, the fractional flow reserve market is expected to grow, offering improved patient outcomes and enhanced diagnostic accuracy.
Fractional Flow Reserve (FFR) is an innovative diagnostic technique used to measure the pressure differences across coronary artery stenosis to assess the severity of the blockage. This method helps determine whether a particular stenosis is responsible for limiting the blood supply to the heart muscle and, thus, whether it necessitates interventional procedures such as angioplasty or stenting. The global fractional flow reserve market is burgeoning, driven by the rising prevalence of cardiovascular diseases, advancements in medical technology, and the increasing adoption of minimally invasive diagnostic procedures. Also, the global fractional flow reserve market growth is fueled by several key factors, including the rising incidence of coronary artery diseases (CAD), the aging global population, and the enhanced accuracy and reliability of FFR over traditional diagnostic methods.
MARKET TRENDS & DRIVERS
Next-Generation Devices Augmenting Non-Invasive FFR Methods
FFR is considered the gold standard in determining the hemodynamic significance of coronary artery disease lesions. Despite encouragement and more benefits, the use of FFR is limited because it requires the use of vasodilator drugs, such as adenosine, which can increase procedure time, costs, and patient discomfort. However, the next generation of products has changed the scenario for patients and end-users. For instance, Acist Medical Systems, a Bracco Group Company, launched its ACIST RXi Mini System, the next-generation RXi Rapid Exchange FFR System, in the fractional flow reserve (FFR) market. The RXi Mini is designed to provide FFR measurements to complement angiography, provide qualitative assessment of lesion severity, and inform intervention strategy in diagnosing and treating coronary and peripheral artery disease.
Favorable Reimbursement Support & Regulatory Approvals
In the dynamic landscape of healthcare technology, reimbursement support and regulatory approvals are pivotal factors that shape market opportunities, particularly in advanced diagnostic tools like FFR. Regulatory approvals are essential for ensuring the safety, efficacy, and quality of medical devices like FFR systems. Regulatory bodies, such as the FDA in the US, CE Mark in Europe, and national health authorities in other regions, assess and approve FFR devices based on rigorous clinical and technical evaluations. Furthermore, the convergence of favorable reimbursement support and regulatory approvals creates significant opportunities in the fractional flow reserve market. Access to reimbursement drives market growth by incentivizing healthcare providers to integrate FFR technology into routine clinical practice, expanding the addressable market for FFR devices. Regulatory approvals spur innovation in FFR technology, leading to the development next-generation devices with enhanced features, such as wireless FFR systems, AI-driven algorithms for real-time data analysis, and integration with digital health platforms.
Increasing Number of CATH Labs
Cath Labs are specialized facilities with advanced imaging technology and interventional equipment primarily used for diagnosing and treating various cardiovascular conditions. These labs enable cardiologists to perform diagnostic procedures such as coronary angiography, FFR measurements, and therapeutic interventions like angioplasty and stenting. The availability and accessibility of Cath Labs are crucial factors in delivering timely and effective cardiovascular care. Out-of-hospital facilities have become important care settings for routine, minimally invasive procedures. Image-guided procedures have become one of the significant parts of hospitals. One such procedure is the FFR, and an FFR CT procedure is largely performed in CATH Labs. In cardiac CATH labs, FFR usage has gone high and supported the growth of the fractional flow reserve market. One of the major advantages of the use of FFR is that it distinguishes significant lesions from non-significant lesions in patients with accurate coronary syndrome and patients with multivessel CAD undergoing urgent or elective catheterization.
SEGMENTATION INSIGHTS
INSIGHTS BY TECHNOLOGY
The global fractional flow reserve market by technology is segmented into non-invasive monitoring and invasive monitoring (FFR guidewires and FFR systems). The non-invasive monitoring segment holds the majority of the segmental share in 2023. Non-invasive FFR technology, particularly FFR derived from coronary computed tomography angiography (FFR-CT), represents a significant advancement. This method uses advanced imaging and computational algorithms to assess the hemodynamic significance of coronary stenoses without requiring invasive procedures. Non-invasive technology eliminates the risks associated with invasive procedures, improving patient comfort and safety. It can be used for initial diagnosis and ongoing monitoring, expanding its use beyond interventional settings. Non-invasive FFR is gaining traction due to its convenience and safety, with significant uptake in regions with advanced healthcare systems. Advances in imaging technology and computational algorithms continue to enhance the accuracy and reliability of non-invasive FFR. Furthermore, the invasive FFR provides precise and reliable measurements for accurately assessing coronary lesions. The technology offers real-time feedback during procedures, aiding immediate clinical decision-making. Invasive FFR is well-supported by clinical guidelines from major cardiology societies, promoting its use in clinical practice.
INSIGHTS BY APPLICATION
The single-vessel application holds the most significant share of the global fractional flow reserve market in 2023. In single-vessel disease, FFR is used to assess the severity of stenosis in one coronary artery. This application is crucial for determining whether a single lesion significantly impairs blood flow and warrants intervention. FFR provides highly accurate diagnostic information, helping to distinguish hemodynamically significant lesions from those that are not. This reduces unnecessary procedures and focuses treatment on clinically relevant stenoses. For single-vessel disease, FFR helps interventional cardiologists make informed decisions about the need for percutaneous coronary intervention (PCI) or stenting. Also, in multi-vessel disease, FFR is used to evaluate multiple coronary arteries to identify which stenoses are functionally significant. This comprehensive approach is essential for planning complex revascularization strategies.
INSIGHTS BY END-USER
The global fractional flow reserve market by end-user is segmented into hospitals, office-based labs, diagnostic imaging centers, and others. The hospitals segment held the most dominant global market share in 2023. Hospitals lead the market due to their advanced infrastructure and high patient volumes, while office-based labs offer efficiency and cost advantages. Diagnostic imaging centers expand their diagnostic capabilities with FFR integration, and other end-users like academic institutions, ASCs, and emerging markets drive innovation and broader adoption. Also, hospitals are equipped with state-of-the-art catheterization labs necessary for performing FFR procedures. Their advanced infrastructure supports the adoption of complex technologies. Hospitals handle a large number of cardiac patients, increasing the demand for accurate diagnostic tools like FFR to guide clinical decisions and improve patient outcomes. Hospitals provide a wide range of diagnostic and therapeutic services, allowing for integrated patient care and the use of FFR in conjunction with other treatments. Furthermore, diagnostic imaging centers focus on providing accurate and timely diagnostic services, making FFR a valuable addition to their capabilities. These centers can integrate FFR technology with other imaging modalities (e.g., CT, MRI), enhancing the comprehensiveness of cardiovascular assessments. Diagnostic imaging centers offer patients easier access to advanced diagnostic tools in various settings.
GEOGRAPHICAL ANALYSIS
North America dominated the global fractional flow reserve market, accounting for a share of 39% in 2023. Driven by the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong adoption of innovative technologies, the regional market is poised for continued expansion. Key players such as Abbott, Boston Scientific, GE Healthcare, Koninklijke Philips, Siemens Healthineers, and HeartFlow lead the market with their cutting-edge products and solutions. Despite challenges related to costs, training, and competitive technologies, the future of the FFR market in North America looks promising, with trends pointing towards greater integration with digital health, AI, non-invasive technologies, and efforts to improve healthcare access.
The Europe fractional flow reserve market is poised for significant growth, driven by the rising prevalence of CAD, technological advancements, supportive clinical evidence, and economic benefits. However, the market must address challenges related to cost, technical complexity, regulatory compliance, and competition from non-invasive techniques. Future trends, including the integration with digital health, miniaturization, hybrid diagnostic approaches, and a focus on patient-centered care, will shape the evolution of the market. As the FFR market continues to expand, it will play a crucial role in enhancing the diagnosis and management of coronary artery disease, ultimately improving patient outcomes and healthcare efficiency across Europe. Furthermore, the APAC fractional flow reserve market is poised for substantial growth, driven by rising cardiovascular disease prevalence, technological advancements, increased healthcare expenditure, and supportive government policies. Also, governments in the APAC region are investing heavily in healthcare infrastructure and advanced medical technologies. Increased healthcare spending facilitates adopting FFR technology in hospitals and clinics.
VENDOR LANDSCAPE
The global fractional flow reserve market is highly consolidated, with limited players accounting for a significant market share. Major players dominate the market; however, new entrants have significant growth opportunities. Though the market is dominated by major players, many investigational and small med-tech companies are coming into existence with innovative products and technologies. This indicates that the fractional flow reserve market offers incredible growth opportunities for existing and future/emerging players due to a large pool of patient population with coronary heart diseases and other conditions and comorbidities, resulting in the need for cardiac diagnosis of the patient. Also, most major players focus on implementing strategies such as product launch and approval, marketing and promotion activities, acquisitions, increased R&D investment, and strengthening distribution networks to increase market share and presence.
Some known global fractional flow reserve market players include Abbott, ACIST Medical System, Boston Scientific, Cathworks, Heartflow, GE Healthcare, Koninklijke Philips, Opsens, Siemens Healthineers, and others. Abbott is one of the major players in the FFR market and offers FFR products under the medical device business segment. These products are subject to competition for technological innovation, price, convenience of use, service, product performance, long-term supply contracts, and product potential for overall cost-effectiveness and productivity gains. Some products in this segment may be subject to rapid product obsolescence or regulatory changes. Abbott benefits from some of the technical benefits of its current products, but these benefits may diminish or be eliminated as competitors introduce new products.
SNAPSHOT
The global fractional flow reserve market size is expected to grow at a CAGR of approximately 15.36% from 2023 to 2029.
The following factors are likely to contribute to the growth of the global fractional flow reserve market during the forecast period:
- New Technology Directions in The FFR
- Rising Prevalence of Coronary Artery Disease (CAD)
- Increasing Number of CATH Labs
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global fractional flow reserve market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Abbott Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- ACIST Medical Systems
- Boston Scientific
- CathWorks
- GE Healthcare
- HeartFlow
- Keya Medical
- Koninklijke Philips
- Opsens Medical (Haemonetics)
- Siemens Healthineers
Segmentation by Technology
- Non-invasive Monitoring
- Invasive Monitoring
- FFR Guidewires
- FFR Systems
Segmentation by Applications
- Single-Vessel
- Multi-Vessel
Segmentation by End-User
- Hospitals
- Office-based Labs
- Diagnostic Imaging Centers
- Others
Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Netherlands
- APAC
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
Frequently Asked Questions
How big is the global fractional flow reserve market?
Who are the key players in the global fractional flow reserve market?
What is the growth rate of the global fractional flow reserve market?
What are the significant trends in the fractional flow reserve market?
Which region dominates the global fractional flow reserve market share?
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 GLOBAL FFR MARKET BY TECHNOLOGY, 2023 & 2029 (%)
EXHIBIT 3 GLOBAL FFR MARKET BY APPLICATION, 2023 & 2029 (%)
EXHIBIT 4 GLOBAL FFR MARKET BY END-USER, 2023 & 2029 (%)
EXHIBIT 5 GLOBAL FFR MARKET BY GEOGRAPHY, 2023 & 2029 (%)
EXHIBIT 6 IMPACT OF NEXT-GENERATION DEVICES AUGMENTING NON-INVASIVE FFR METHODS
EXHIBIT 7 ACIST RXI MINI SYSTEM FEATURES
EXHIBIT 8 IMPACT OF FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS
EXHIBIT 9 INCREASE IN TARGET POPULATION ACROSS THE GLOBE
EXHIBIT 10 IMPACT OF AI & ML REVOLUTIONIZING FFR-CT
EXHIBIT 11 IMPACT OF FAVORABLE REIMBURSEMENT SUPPORT & REGULATORY APPROVALS
EXHIBIT 12 IMPACT OF NEW TECHNOLOGY DIRECTIONS IN FFR
EXHIBIT 13 IMPACT OF RISING PREVALENCE OF CORONARY ARTERY DISEASE
EXHIBIT 14 INDICATIONS FOR FFR MANAGEMENT
EXHIBIT 15 IMPACT OF INCREASING NUMBER OF CATH LABS
EXHIBIT 16 IMPACT OF HIGH COST OF FFR
EXHIBIT 17 IMPACT OF LIMITATIONS ASSOCIATED WITH FFR
EXHIBIT 18 IMPACT OF LOW FFR ADOPTION & AVAILABILITY OF SUBSTITUTES
EXHIBIT 19 GLOBAL FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 20 FIVE FORCES ANALYSIS 2023
EXHIBIT 21 INCREMENTAL GROWTH BY TECHNOLOGY 2023 & 2029
EXHIBIT 22 GLOBAL FFR MARKET BY TECHNOLOGY, 2023-2029: INCREMENTAL GROWTH
EXHIBIT 23 GLOBAL FFR MARKET BY TECHNOLOGY 2023-2029: ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL NON-INVASIVE FFR MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 25 GLOBAL NON-INVASIVE FFR MARKET 2020-2029 ($ MILLION)
EXHIBIT 26 GLOBAL INVASIVE FFR MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL INVASIVE MONITORING FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 28 GLOBAL FFR GUIDEWIRES MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL FFR GUIDEWIRES MARKET 2020-2029 ($ MILLION)
EXHIBIT 30 GLOBAL FFR SYSTEMS MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL FFR SYSTEMS MARKET 2020-2029 ($ MILLION)
EXHIBIT 32 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 33 GLOBAL FFR MARKET BY APPLICATIONS 2023–2029: INCREMENTAL GROWTH
EXHIBIT 34 GLOBAL FFR MARKET BY APPLICATIONS 2023-2029: ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL SINGLE-VESSEL FFR MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL SINGLE-VESSEL FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 37 GLOBAL MULTI-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL MULTI-VESSEL FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 40 GLOBAL FFR MARKET BY END-USERS 2023-2029: INCREMENTAL GROWTH
EXHIBIT 41 GLOBAL FFR MARKET BY END-USERS 2023-2029: ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS FFR MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL HOSPITALS FFR MARKET 2020-2029 ($ MILLION)
EXHIBIT 44 GLOBAL OFFICE-BASED LABS FFR MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL OFFICE-BASED LABS FFR MARKET 2020-2029 ($ MILLION)
EXHIBIT 46 GLOBAL DIAGNOSTIC IMAGING CENTERS FFR MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL DIAGNOSTIC IMAGING CENTERS FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 48 GLOBAL OTHERS FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL OTHERS FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 51 GLOBAL FFR MARKET BY GEOGRAPHY 2023–2029: INCREMENTAL GROWTH
EXHIBIT 52 GLOBAL FFR MARKET BY GEOGRAPHY 2023–2029: ABSOLUTE GROWTH
EXHIBIT 53 NORTH AMERICA FFR MARKET: KEY COUNTRIES
EXHIBIT 54 NORTH AMERICA FFR MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 NORTH AMERICA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 56 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 57 US FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 58 CANADA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 59 EUROPE FFR MARKET: KEY COUNTRIES
EXHIBIT 60 EUROPEAN HOSPITALS WITH 24/7 CATH LABS (MILLIONS)
EXHIBIT 61 EUROPE FFR MARKET 2023–2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 EUROPE FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 63 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 64 GERMANY FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 65 FRANCE FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 66 UK FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 67 ITALY FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 68 SPAIN FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 69 RUSSIA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 70 NETHERLANDS FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 71 APAC FFR MARKET: KEY COUNTRIES
EXHIBIT 72 APAC FFR MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 APAC FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 74 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 75 JAPAN FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 76 CHINA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 77 INDIA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 78 SOUTH KOREA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 79 AUSTRALIA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 80 LATIN AMERICA FFR MARKET: KEY COUNTRIES
EXHIBIT 81 LATIN AMERICA FFR MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 82 LATIN AMERICA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 83 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 84 BRAZIL FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 85 MEXICO FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 86 ARGENTINA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 87 COLOMBIA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 88 MIDDLE EAST & AFRICA FFR MARKET: KEY COUNTRIES
EXHIBIT 89 MIDDLE EAST & AFRICA FFR MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 90 MIDDLE EAST & AFRICA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 91 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 92 TURKEY FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 93 SAUDI ARABIA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 94 SOUTH AFRICA FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 95 UAE FFR MARKET 2020–2029 ($ MILLION)
EXHIBIT 96 VENDORS OFFERING FFR: MARKET DOMINANCE ANALYSIS
EXHIBIT 97 VENDORS OFFERING COMMERCIAL FFR: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 98 ABBOTT: TOTAL REVENUE 2021-2023 ($ BILLION)
EXHIBIT 99 ABBOTT: R&D EXPENDITURE 2021-2023 ($ BILLION)
EXHIBIT 100 ABBOTT: REVENUE BY BUSINESS SEGMENT 2022-2023 ($ BILLION)
EXHIBIT 101 ABBOTT: REVENUE BY GEOGRAPHY 2023 ($ BILLION)
EXHIBIT 102 BOSTON SCIENTIFIC: TOTAL REVENUE 2021-2023 ($ BILLION)
EXHIBIT 103 BOSTON SCIENTIFIC: R&D EXPENDITURE 2021-2023 ($ BILLION)
EXHIBIT 104 BOSTON SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2022-2023 ($ BILLION)
EXHIBIT 105 BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY 2023 ($ BILLION)
EXHIBIT 106 GE HEALTHCARE: TOTAL REVENUE 2021-2023 ($ BILLION)
EXHIBIT 107 GE HEALTHCARE: R&D EXPENDITURE 2021-2023 ($ BILLION)
EXHIBIT 108 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2022-2023 ($ BILLION)
EXHIBIT 109 GE HEALTHCARE: REVENUE BY GEOGRAPHY 2023 ($ BILLION)
EXHIBIT 110 KONINKLIJKE PHILIPS: TOTAL REVENUE 2021-2023 ($ BILLION)
EXHIBIT 111 KONINKLIJKE PHILIPS: REVENUE EXPENDITURE 2021-2023 ($ BILLION)
EXHIBIT 112 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2022-2023 ($ BILLION)
EXHIBIT 113 KONINKLIJKE PHILIPS: REVENUE BY GEOGRAPHY 2023 ($ BILLION)
EXHIBIT 114 SIEMENS HEALTHINEERS: TOTAL REVENUE 2021-2023 ($ BILLION)
EXHIBIT 115 SIEMENS HEALTHINEERS: R&D EXPENDITURE 2021-2023 ($ BILLION)
EXHIBIT 116 KEY CAVEATS
LIST OF TABLES
TABLE 1 EXAMPLES OF NEXT-GENERATION FFR PRESSUREWIRE
TABLE 2 COMPARISON OF IMAGE-DERIVED FFR SYSTEM
TABLE 3 APPROXIMATE COST PER STAGES IN FFR CT($)
TABLE 4 FFR PRESSURE GUIDEWIRE FAILURE AND ASSOCIATED ADVERSE EVENTS (COMPARISON AMONG DIFFERENT GUIDEWIRES)
TABLE 5 GLOBAL NON-INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 6 GLOBAL NON-INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 7 COMPARISON OF INVASIVE FFR MONITORING METHODS WITH SPECIFICATIONS
TABLE 8 GLOBAL INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 9 GLOBAL INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 10 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 11 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 12 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 13 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 14 GLOBAL HOSPITALS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 15 GLOBAL HOSPITALS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 16 GLOBAL OFFICE-BASED LABS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 17 GLOBAL OFFICE-BASED LABS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 18 GLOBAL DIAGNOSTIC IMAGING CENTERS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 19 GLOBAL DIAGNOSTIC IMAGING CENTERS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 20 GLOBAL OTHERS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 21 GLOBAL OTHERS MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 22 NORTH AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 23 NORTH AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 24 NORTH AMERICA FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 25 NORTH AMERICA FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 26 NORTH AMERICA FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 27 NORTH AMERICA FFR MARKET BY END-USER 2023−2029 (%)
TABLE 28 EUROPE FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 29 EUROPE FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 30 EUROPE FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 31 EUROPE FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 32 EUROPE FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 33 EUROPE FFR MARKET BY END-USER 2023−2029 (%)
TABLE 34 APAC FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 35 APAC FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 36 APAC FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 37 APAC FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 38 APAC FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 39 APAC FFR MARKET BY END-USER 2023−2029 (%)
TABLE 40 LATIN AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 41 LATIN AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 42 LATIN AMERICA FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 43 LATIN AMERICA FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 44 LATIN AMERICA FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 45 LATIN AMERICA FFR MARKET BY END-USER 2023−2029 (%)
TABLE 46 MIDDLE EAST & AFRICA FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 47 MIDDLE EAST & AFRICA FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 48 MIDDLE EAST & AFRICA FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 49 MIDDLE EAST & AFRICA FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 50 MIDDLE EAST & AFRICA FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 51 MIDDLE EAST & AFRICA FFR MARKET BY END-USER 2023−2029 (%)
TABLE 52 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 53 ACIST MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 54 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 55 CATHWORKS: MAJOR PRODUCT OFFERINGS
TABLE 56 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 57 HEARTFLOW: MAJOR PRODUCT OFFERINGS
TABLE 58 KEYA MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 59 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 60 OPSENS MEDICAL (HAEMONETICS): MAJOR PRODUCT OFFERINGS
TABLE 61 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 62 GLOBAL FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 63 GLOBAL FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 64 NORTH AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 65 NORTH AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 66 EUROPE FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 67 EUROPE FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 68 APAC FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 69 APAC FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 70 LATIN AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 71 LATIN AMERICA FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 72 MIDDLE EAST & AFRICA FFR MARKET BY TECHNOLOGY 2023−2029 ($ MILLION)
TABLE 73 MIDDLE EAST & AFRICA FFR MARKET BY TECHNOLOGY 2023−2029 (%)
TABLE 74 GLOBAL FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 75 GLOBAL FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 76 NORTH AMERICA FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 77 NORTH AMERICA FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 78 EUROPE FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 79 EUROPE FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 80 APAC FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 81 APAC FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 82 LATIN AMERICA FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 83 LATIN AMERICA FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 84 MIDDLE EAST & AFRICA FFR MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 85 MIDDLE EAST & AFRICA FFR MARKET BY APPLICATION 2023−2029 (%)
TABLE 86 GLOBAL FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 87 GLOBAL FFR MARKET BY END-USER 2023−2029 (%)
TABLE 88 NORTH AMERICA FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 89 NORTH AMERICA FFR MARKET BY END-USER 2023−2029 (%)
TABLE 90 EUROPE FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 91 EUROPE FFR MARKET BY END-USER 2023−2029 (%)
TABLE 92 APAC FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 93 APAC FFR MARKET BY END-USER 2023−2029 (%)
TABLE 94 LATIN AMERICA FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 95 LATIN AMERICA FFR MARKET BY END-USER 2023−2029 (%)
TABLE 96 MIDDLE EAST & AFRICA FFR MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 97 MIDDLE EAST & AFRICA FFR MARKET BY END-USER 2023−2029 (%)
TABLE 98 GLOBAL FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 99 GLOBAL FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 100 GLOBAL NON-INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 101 GLOBAL NON-INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 102 GLOBAL INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 103 GLOBAL INVASIVE MONITORING FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 104 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 105 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 106 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 107 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 108 GLOBAL HOSPITALS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 109 GLOBAL HOSPITALS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 110 GLOBAL OFFICE-BASED LABS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 111 GLOBAL OFFICE-BASED LABS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 112 GLOBAL DIAGNOSTIC IMAGING CENTERS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 113 GLOBAL DIAGNOSTIC IMAGING CENTERS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 114 GLOBAL OTHERS FFR MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 115 GLOBAL OTHERS FFR MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 116 CURRENCY CONVERSION 2016−2023
1. SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. MARKET SEGMENTATION
1.2.1. MARKET BY TECHNOLOGY
1.2.2. MARKET BY APPLICATIONS
1.2.3. MARKET BY END-USER
1.2.4. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. BASE YEAR
2. PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
3. MARKET AT A GLANCE
4. INTRODUCTION
4.1. OVERVIEW
4.2. FFR: AN OVERVIEW
5. MARKET OPPORTUNITIES & TRENDS
5.1. NEXT-GENERATION DEVICES AUGMENTING NON-INVASIVE FFR METHODS
5.2. FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS
5.3. AI & ML REVOLUTIONIZING FFR-CT
5.4. FAVORABLE REIMBURSEMENT SUPPORT & REGULATORY APPROVALS
6. MARKET GROWTH ENABLERS
6.1. NEW TECHNOLOGY DIRECTIONS IN FFR
6.2. RISING PREVALENCE OF CORONARY ARTERY DISEASE
6.3. INCREASING NUMBER OF CATH LABS
7. MARKET RESTRAINTS
7.1. HIGH COST OF FFR
7.2. LIMITATIONS ASSOCIATED WITH FFR
7.3. LOW FFR ADOPTION & AVAILABILITY OF SUBSTITUTES
8. MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9. TECHNOLOGY
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. NON-INVASIVE MONITORING
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. NON-INVASIVE MONITORING MARKET BY GEOGRAPHY
9.4. INVASIVE MONITORING
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. FFR GUIDEWIRES
9.4.4. MARKET SIZE & FORECAST
9.4.5. FFR SYSTEMS
9.4.6. MARKET SIZE & FORECAST
9.4.7. INVASIVE MONITORING BY GEOGRAPHY
10. APPLICATIONS
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. SINGLE-VESSEL
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. SINGLE-VESSEL BY GEOGRAPHY
10.4. MULTI-VESSEL
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MULTI-VESSEL BY GEOGRAPHY
11. END-USER
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. HOSPITALS
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. HOSPITALS BY GEOGRAPHY
11.4. OFFICE-BASED LABS
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. OFFICE-BASED LABS BY GEOGRAPHY
11.5. DIAGNOSTIC IMAGING CENTERS
11.5.1. MARKET OVERVIEW
11.5.2. MARKET SIZE & FORECAST
11.5.3. DIAGNOSTIC IMAGING CENTERS BY GEOGRAPHY
11.6. OTHERS
11.6.1. MARKET OVERVIEW
11.6.2. MARKET SIZE & FORECAST
11.6.3. OTHERS BY GEOGRAPHY
12. GEOGRAPHY
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. GEOGRAPHIC OVERVIEW
13. NORTH AMERICA
13.1. MARKET OVERVIEW
13.2. MARKET SIZE & FORECAST
13.2.1. NORTH AMERICA BY TECHNOLOGY
13.2.2. NORTH AMERICA BY APPLICATION
13.2.3. NORTH AMERICA BY END-USER
13.3. KEY COUNTRIES
13.3.1. US: MARKET SIZE & FORECAST
13.3.2. CANADA: MARKET SIZE & FORECAST
14. EUROPE
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.2.1. EUROPE BY TECHNOLOGY
14.2.2. EUROPE BY APPLICATION
14.2.3. EUROPE BY END-USER
14.3. KEY COUNTRIES
14.3.1. GERMANY: MARKET SIZE & FORECAST
14.3.2. FRANCE: MARKET SIZE & FORECAST
14.3.3. UK: MARKET SIZE & FORECAST
14.3.4. ITALY: MARKET SIZE & FORECAST
14.3.5. SPAIN: MARKET SIZE & FORECAST
14.3.6. RUSSIA: MARKET SIZE & FORECAST
14.3.7. NETHERLANDS: MARKET SIZE & FORECAST
15. APAC
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.2.1. APAC BY TECHNOLOGY
15.2.2. APAC BY APPLICATION
15.2.3. APAC BY END-USER
15.3. KEY COUNTRIES
15.3.1. JAPAN: MARKET SIZE & FORECAST
15.3.2. CHINA: MARKET SIZE & FORECAST
15.3.3. INDIA: MARKET SIZE & FORECAST
15.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
15.3.5. AUSTRALIA: MARKET SIZE & FORECAST
16. LATIN AMERICA
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.2.1. LATIN AMERICA BY TECHNOLOGY
16.2.2. LATIN AMERICA BY APPLICATION
16.2.3. LATIN AMERICA BY END-USER
16.3. KEY COUNTRIES
16.3.1. BRAZIL: MARKET SIZE & FORECAST
16.3.2. MEXICO: MARKET SIZE & FORECAST
16.3.3. ARGENTINA: MARKET SIZE & FORECAST
16.3.4. COLOMBIA: MARKET SIZE & FORECAST
17. MIDDLE EAST & AFRICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.2.1. MIDDLE EAST & AFRICA BY TECHNOLOGY
17.2.2. MIDDLE EAST & AFRICA BY APPLICATION
17.2.3. MIDDLE EAST & AFRICA BY END-USER
17.3. KEY COUNTRIES
17.3.1. TURKEY: MARKET SIZE & FORECAST
17.3.2. SAUDI ARABIA: MARKET SIZE & FORECAST
17.3.3. SOUTH AFRICA: MARKET SIZE & FORECAST
17.3.4. UAE: MARKET SIZE & FORECAST
18. COMPETITIVE LANDSCAPE
18.1. COMPETITION OVERVIEW
18.2. MARKET SHARE ANALYSIS
18.2.1. ABBOTT
18.2.2. ACIST MEDICAL SYSTEMS
18.2.3. BOSTON SCIENTIFIC
18.2.4. CATHWORKS
18.2.5. GE HEALTHCARE
18.2.6. HEARTFLOW
18.2.7. KEYA MEDICAL
18.2.8. KONINKLIJKE PHILIPS
18.2.9. OPSENS
18.2.10. SIEMENS HEALTHINEERS
19. KEY COMPANY PROFILES
19.1. ABBOTT
19.1.1. BUSINESS OVERVIEW
19.1.2. PRODUCT OFFERINGS
19.1.3. KEY STRATEGIES
19.1.4. KEY STRENGTHS
19.1.5. KEY OPPORTUNITIES
19.2. ACIST MEDICAL SYSTEMS
19.2.1. BUSINESS OVERVIEW
19.2.2. PRODUCT OFFERINGS
19.2.3. KEY STRATEGIES
19.2.4. KEY STRENGTHS
19.2.5. KEY OPPORTUNITIES
19.3. BOSTON SCIENTIFIC
19.3.1. BUSINESS OVERVIEW
19.3.2. PRODUCT OFFERINGS
19.3.3. KEY STRATEGIES
19.3.4. KEY STRENGTHS
19.3.5. KEY OPPORTUNITIES
19.4. CATHWORKS
19.4.1. BUSINESS OVERVIEW
19.4.2. PRODUCT OFFERINGS
19.4.3. KEY STRATEGIES
19.4.4. KEY STRENGTHS
19.4.5. KEY OPPORTUNITIES
19.5. GE HEALTHCARE
19.5.1. BUSINESS OVERVIEW
19.5.2. PRODUCT OFFERINGS
19.5.3. KEY STRATEGIES
19.5.4. KEY STRENGTHS
19.5.5. KEY OPPORTUNITIES
19.6. HEARTFLOW INC.
19.6.1. BUSINESS OVERVIEW
19.6.2. PRODUCT OFFERINGS
19.6.3. KEY STRATEGIES
19.6.4. KEY STRENGTHS
19.6.5. KEY OPPORTUNITIES
19.7. KEYA MEDICAL
19.7.1. BUSINESS OVERVIEW
19.7.2. PRODUCT OFFERINGS
19.7.3. KEY STRATEGIES
19.7.4. KEY STRENGTHS
19.7.5. KEY OPPORTUNITIES
19.8. KONINKLIJKE PHILIPS
19.8.1. BUSINESS OVERVIEW
19.8.2. PRODUCT OFFERINGS
19.8.3. KEY STRATEGIES
19.8.4. KEY STRENGTHS
19.8.5. KEY OPPORTUNITIES
19.9. OPSENS MEDICAL (HAEMONETICS)
19.9.1. BUSINESS OVERVIEW
19.9.2. PRODUCT OFFERINGS
19.9.3. KEY STRATEGIES
19.9.4. KEY STRENGTHS
19.9.5. KEY OPPORTUNITIES
19.10. SIEMENS HEALTHINEERS
19.10.1. BUSINESS OVERVIEW
19.10.2. PRODUCT OFFERINGS
19.10.3. KEY STRATEGIES
19.10.4. KEY STRENGTHS
19.10.5. KEY OPPORTUNITIES
20. REPORT SUMMARY
20.1. KEY TAKEAWAYS
20.2. STRATEGIC RECOMMENDATIONS
21. QUANTITATIVE SUMMARY
21.1. MARKET BY TECHNOLOGY
21.1.1. NORTH AMERICA BY TECHNOLOGY
21.1.2. EUROPE BY TECHNOLOGY
21.1.3. APAC BY TECHNOLOGY
21.1.4. LATIN AMERICA BY TECHNOLOGY
21.1.5. MIDDLE EAST & AFRICA BY TECHNOLOGY
21.2. MARKET BY APPLICATION
21.2.1. NORTH AMERICA BY APPLICATION
21.2.2. EUROPE BY APPLICATION
21.2.3. APAC BY APPLICATION
21.2.4. LATIN AMERICA BY APPLICATION
21.2.5. MIDDLE EAST & AFRICA BY APPLICATION
21.3. MARKET BY END-USER
21.3.1. NORTH AMERICA BY END-USER
21.3.2. EUROPE BY END-USER
21.3.3. APAC BY END-USER
21.3.4. LATIN AMERICA BY END-USER
21.3.5. MIDDLE EAST & AFRICA BY END-USER
21.4. MARKET BY GEOGRAPHY
21.4.1. NON-INVASIVE MONITORING MARKET BY GEOGRAPHY
21.4.2. INVASIVE MONITORING BY GEOGRAPHY
21.4.3. SINGLE-VESSEL BY GEOGRAPHY
21.4.4. MULTI-VESSEL BY GEOGRAPHY
21.4.5. HOSPITALS BY GEOGRAPHY
21.4.6. OFFICE-BASED LABS BY GEOGRAPHY
21.4.7. DIAGNOSTIC IMAGING CENTERS BY GEOGRAPHY
21.4.8. OTHERS BY GEOGRAPHY
22. APPENDIX
22.1. RESEARCH METHODOLOGY
22.2. RESEARCH PROCESS
22.3. REPORT ASSUMPTIONS & CAVEATS
22.3.1. KEY CAVEATS
22.3.2. CURRENCY CONVERSION
22.4. ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the global fractional flow reserve market?
Who are the key players in the global fractional flow reserve market?
What is the growth rate of the global fractional flow reserve market?
What are the significant trends in the fractional flow reserve market?
Which region dominates the global fractional flow reserve market share?
Other RELATED Reports
